Mammographically Occult Breast Cancers Detected with AI-based Diagnosis Supporting Software: Clinical and Histopathologic Characteristics

Overview

Journal Insights Imaging

Publisher Springer

Specialty Radiology

Date 2022 Mar 29

PMID 35347508

Authors

Hee Jeong Kim

Hak Hee Kim

Ki Hwan Kim

Woo Jung Choi

Eun Young Chae

Hee Jung Shin

Joo Hee Cha

Woo Hyun Shim

Affiliations

Soon will be listed here.

Abstract

Background: To demonstrate the value of an artificial intelligence (AI) software in the detection of mammographically occult breast cancers and to determine the clinicopathologic patterns of the cancers additionally detected using the AI software.

Methods: By retrospectively reviewing our institutional database (January 2017-September 2019), we identified women with mammographically occult breast cancers and analyzed their mammography with an AI software that provided a malignancy score (range 0-100; > 10 considered as positive). The hot spots in the AI report were compared with the US and MRI findings to determine if the cancers were correctly marked by the AI software. The clinicopathologic characteristics of the AI-detected cancers were analyzed and compared with those of undetected cancers.

Results: Among the 1890 breast cancers, 6.8% (128/1890) were mammographically occult, among which 38.3% (49/128) had positive results in the AI analysis. Of them, 81.6% (40/49) were correctly marked by the AI software and determined as "AI-detected cancers." As such, 31.3% (40/128) of mammographically occult breast cancers could be identified by the AI software. Of the AI-detected cancers, 97.5% were found in heterogeneously or extremely dense breasts, 52.5% were asymptomatic, 86.5% were invasive, and 29.7% had axillary lymph node metastasis. Compared with undetected cancers, the AI-detected cancers were more likely to be found in younger patients (p < 0.001), undergo neoadjuvant chemotherapy as well as mastectomy rather than breast-conserving operation (both p < 0.001), and accompany axillary lymph node metastasis (p = 0.003).

Conclusions: AI conferred an added value in the detection of mammographically occult breast cancers.

Citing Articles

A multimodal machine learning model for the stratification of breast cancer risk.

Qian X, Pei J, Han C, Liang Z, Zhang G, Chen N Nat Biomed Eng. 2024; .

PMID: 39633027 DOI: 10.1038/s41551-024-01302-7.

Navigating the Metaverse: A New Virtual Tool with Promising Real Benefits for Breast Cancer Patients.

Zydowicz W, Skokowski J, Marano L, Polom K J Clin Med. 2024; 13(15).

PMID: 39124604 PMC: 11313674. DOI: 10.3390/jcm13154337.

Use of a commercial artificial intelligence-based mammography analysis software for improving breast ultrasound interpretations.

Kim H, Kim H, Kim K, Lee J, Choi W, Chae E Eur Radiol. 2024; 34(10):6320-6331.

PMID: 38570382 DOI: 10.1007/s00330-024-10718-3.

Improving mammography interpretation for both novice and experienced readers: a comparative study of two commercial artificial intelligence software.

Kim H, Choi W, Gwon H, Jang S, Chae E, Shin H Eur Radiol. 2023; 34(6):3924-3934.

PMID: 37938383 DOI: 10.1007/s00330-023-10422-8.

Artificial Intelligence Improves Detection of Supplemental Screening Ultrasound-detected Breast Cancers in Mammography.

Yoen H, Chang J J Breast Cancer. 2023; 26(5):504-513.

PMID: 37704383 PMC: 10625864. DOI: 10.4048/jbc.2023.26.e39.

References

Qiu Y, Yan S, Gundreddy R, Wang Y, Cheng S, Liu H . A new approach to develop computer-aided diagnosis scheme of breast mass classification using deep learning technology. J Xray Sci Technol. 2017; 25(5):751-763. PMC: 5647205. DOI: 10.3233/XST-16226. View

Wu N, Phang J, Park J, Shen Y, Huang Z, Zorin M . Deep Neural Networks Improve Radiologists' Performance in Breast Cancer Screening. IEEE Trans Med Imaging. 2019; 39(4):1184-1194. PMC: 7427471. DOI: 10.1109/TMI.2019.2945514. View

Rodriguez-Ruiz A, Lang K, Gubern-Merida A, Teuwen J, Broeders M, Gennaro G . Can we reduce the workload of mammographic screening by automatic identification of normal exams with artificial intelligence? A feasibility study. Eur Radiol. 2019; 29(9):4825-4832. PMC: 6682851. DOI: 10.1007/s00330-019-06186-9. View

Kooi T, Litjens G, van Ginneken B, Gubern-Merida A, Sanchez C, Mann R . Large scale deep learning for computer aided detection of mammographic lesions. Med Image Anal. 2016; 35:303-312. DOI: 10.1016/j.media.2016.07.007. View

Hosny A, Parmar C, Quackenbush J, Schwartz L, Aerts H . Artificial intelligence in radiology. Nat Rev Cancer. 2018; 18(8):500-510. PMC: 6268174. DOI: 10.1038/s41568-018-0016-5. View

Geras K, Mann R, Moy L . Artificial Intelligence for Mammography and Digital Breast Tomosynthesis: Current Concepts and Future Perspectives. Radiology. 2019; 293(2):246-259. PMC: 6822772. DOI: 10.1148/radiol.2019182627. View

Majid A, de Paredes E, Doherty R, Sharma N, Salvador X . Missed breast carcinoma: pitfalls and pearls. Radiographics. 2003; 23(4):881-95. DOI: 10.1148/rg.234025083. View

Ribli D, Horvath A, Unger Z, Pollner P, Csabai I . Detecting and classifying lesions in mammograms with Deep Learning. Sci Rep. 2018; 8(1):4165. PMC: 5854668. DOI: 10.1038/s41598-018-22437-z. View

McKinney S, Sieniek M, Godbole V, Godwin J, Antropova N, Ashrafian H . International evaluation of an AI system for breast cancer screening. Nature. 2020; 577(7788):89-94. DOI: 10.1038/s41586-019-1799-6. View

10.

Kim H, Kim H, Han B, Kim K, Han K, Nam H . Changes in cancer detection and false-positive recall in mammography using artificial intelligence: a retrospective, multireader study. Lancet Digit Health. 2020; 2(3):e138-e148. DOI: 10.1016/S2589-7500(20)30003-0. View

11.

Sechopoulos I, Mann R . Stand-alone artificial intelligence - The future of breast cancer screening?. Breast. 2020; 49:254-260. PMC: 7375643. DOI: 10.1016/j.breast.2019.12.014. View

12.

Topol E . High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019; 25(1):44-56. DOI: 10.1038/s41591-018-0300-7. View

13.

Howlader N, Altekruse S, Li C, Chen V, Clarke C, Ries L . US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst. 2014; 106(5). PMC: 4580552. DOI: 10.1093/jnci/dju055. View

14.

Kohler B, Sherman R, Howlader N, Jemal A, Ryerson A, Henry K . Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. J Natl Cancer Inst. 2015; 107(6):djv048. PMC: 4603551. DOI: 10.1093/jnci/djv048. View

15.

Kim E, Kim H, Han K, Kang B, Sohn Y, Woo O . Applying Data-driven Imaging Biomarker in Mammography for Breast Cancer Screening: Preliminary Study. Sci Rep. 2018; 8(1):2762. PMC: 5807343. DOI: 10.1038/s41598-018-21215-1. View

16.

Choy G, Khalilzadeh O, Michalski M, Do S, Samir A, Pianykh O . Current Applications and Future Impact of Machine Learning in Radiology. Radiology. 2018; 288(2):318-328. PMC: 6542626. DOI: 10.1148/radiol.2018171820. View

17.

Kang S, Kim Y, Kim Z, Kim H, Kim H, Park S . Breast Cancer Statistics in Korea in 2017: Data from a Breast Cancer Registry. J Breast Cancer. 2020; 23(2):115-128. PMC: 7192743. DOI: 10.4048/jbc.2020.23.e24. View

18.

Dembrower K, Wahlin E, Liu Y, Salim M, Smith K, Lindholm P . Effect of artificial intelligence-based triaging of breast cancer screening mammograms on cancer detection and radiologist workload: a retrospective simulation study. Lancet Digit Health. 2020; 2(9):e468-e474. DOI: 10.1016/S2589-7500(20)30185-0. View

19.

Rodriguez-Ruiz A, Krupinski E, Mordang J, Schilling K, Heywang-Kobrunner S, Sechopoulos I . Detection of Breast Cancer with Mammography: Effect of an Artificial Intelligence Support System. Radiology. 2018; 290(2):305-314. DOI: 10.1148/radiol.2018181371. View

20.

Broeders M, Onland-Moret N, Rijken H, Hendriks J, Verbeek A, Holland R . Use of previous screening mammograms to identify features indicating cases that would have a possible gain in prognosis following earlier detection. Eur J Cancer. 2003; 39(12):1770-5. DOI: 10.1016/s0959-8049(03)00311-3. View